• Those Who Purchased Basilea Pharmaceutica (VTX:BSLN) Shares Five Years Ago Have A 45% Loss To Show For It

    It is a pleasure to report that the Basilea Pharmaceutica AG (VTX:BSLN) is up 43% in the last quarter. But that...


  • JPMorgan Says Short U.S. 30-Year Bond on Excess Haven Demand

    (Bloomberg) -- JPMorgan Chase & Co. strategists are betting that the surge in demand for Treasuries thanks to fears about the deadly coronavirus will prove short-lived, sticking with a call to sell longer-dated bonds.Among the Wall Street bank’s other takeaways from their latest market-outlook reports: the outbreak of the disease is a “clear negative” for emerging Asian currencies, while for stocks it could be a buying opportunity if historical parallels hold.“This is the latest risk of a series that have driven U.S. Treasury yields far below what fundamentals indicate,” strategists including Matthew Jozoff wrote in a note Friday. “We don’t intend to be dismissive of the coronavirus, as it is a serious concern both in human and economic turns,” they wrote, while flagging that JPMorgan analysis notes a trend toward reduced mortality in health epidemics over time.Geopolitical tensions stemming from Iran spurred a rally in Treasuries earlier this month, before the coronavirus emerged as a new threat to global economic growth. The bond bid extended on Monday, with 10-year U.S. yields sliding as low as 1.62%, the lowest since October.That latest leg down came after JPMorgan strategists had calculated that yields were almost 30 basis points “too low” compared with expectations for growth, inflation and Federal Reserve policy decisions, along with gauges of investor positioning and the share of negative-yielding debt in developed markets.“Ten-year Treasuries have not been this dislocated on this basis since a brief period in the spring of 2015,” JPMorgan calculated. “We remain short 30-year U.S. Treasuries.”‘Buying Opportunities’Turning to stocks, JPMorgan’s equity strategists flagged that the health-scare could lead to more near-term declines, while concluding that “past pandemics episodes didn’t lead to sustained selling, they tended to ultimately be buying opportunities.”On the currency side, JPMorgan shifted its emerging Asia position to neutral, thanks to closing its overweight recommendation on Malaysia’s ringgit, which on Friday snapped a four-week winning streak.“Such outbreaks can subside as quickly as they have emerged,” JPMorgan currency strategists led by Paul Meggyesi wrote. “However, previous episodes show that risk appetite can be disrupted for at least a number of weeks, particularly from an FX standpoint.”(Adds comments on stocks and currencies starting in second paragraph.)To contact the reporter on this story: Christopher Anstey in Tokyo at canstey@bloomberg.netTo contact the editors responsible for this story: Chris Nagi at chrisnagi@bloomberg.net, Cormac Mullen, Ravil ShirodkarFor more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.


  • Don't Sell China East Education Holdings Limited (HKG:667) Before You Read This

    The goal of this article is to teach you how to use price to earnings ratios (P/E ratios). To keep it practical, we'll...


  • Those Who Purchased Endomines (STO:ENDO) Shares Five Years Ago Have A 88% Loss To Show For It

    Endomines AB (publ) (STO:ENDO) shareholders should be happy to see the share price up 16% in the last month. But that...


  • Arix Co-founds Quench Bio With Series A Financing

    Arix Bioscience plc ("Arix", LSE: ARIX) a global venture capital company focused on investing in and building breakthrough biotech companies, today announces that its discovery portfolio company Quench Bio has emerged from stealth mode with the completion of a Series A financing. This follows a period of company creation, with seed investment and close involvement by Arix.


  • Finastra Strengthens Its Position in Israel With New Office Opening

    Finastra is investing further in Israel with a new office in Kfar Saba, just outside Tel Aviv. The office, which is home to over 330 employees, offers more space for the Finastra team to grow as the company strengthens its position in the country, and provides an ultra-modern workspace to inspire creativity and facilitate collaboration. The move will help the company support technological and financial innovation in the region, and drive adoption of its open development platform, FusionFabric.cloud.


  • Reiss Holdings Limited reports strong like-for-like sales over the Christmas period and continues to expand its global footprint

    Reiss Holdings Limited, the premium international fashion brand, today reported Christmas trading figures for 7 weeks to 18th January 2020.


  • Quench Bio Closes $50M Series A Financing to Advance First-in-Class Medicines Targeting Gasdermin to Treat Severe Inflammatory Diseases

    Quench Bio, a company leveraging new insights into gasdermin biology and innate immunology to develop medicines for severe inflammatory diseases, today announced the completion of a $50 million Series A financing led by RA Capital Management ("RA Capital"), with participation from new Investor Abbvie Ventures. Atlas Venture ("Atlas") and Arix Bioscience plc ("Arix", LSE: ARIX) who co-founded and seeded the company, also participated in the Series A. Quench Bio has incubated at Atlas since inception.


  • Crowe Global Reports Eight Years of Consecutive Growth

    Crowe Global (Crowe) reports an outstanding eight years of consecutive growth. The eighth largest audit, tax and advisory network in the world announced global revenues of US$4.4.bn in 2019, an increase of 3.5% (excluding Forex impact).


  • Industry Leaders Back new Specialist led Investment Company for Technology Start-ups

    Bloc Ventures Limited (Bloc), the venture capital company focussed on early stage European deep technology investment, today announces it has raised over £20m in equity funding from UK industry leaders.


(ARA) - Tax time is a stressful time, even for the most prepared filer. And for the many people who aren't perfectly prepared when the season rolls around, each commercial, ad or sign that mentions tax preparation can be a painful reminder that the daunting task still lies ahead.

This year, don't let yourself be affected by the stress - or at least find ways to cut back on it. By avoiding these six common mistakes, you'll be making the process of filing your taxes a lot easier on yourself.

Mistake 1: Rushing to file by April 15
If you aren't ready by the 15th, you don't need to panic. Six month extensions are now an easy-to-use option. You no longer have to give a reason about why your taxes aren't ready by the initial deadline - just fill out and file Form 4868, and you'll give yourself some extra time to get it all complete.

Mistake 2: Being a perfectionist
Of course, you can't and don't want to lie on your tax return, but you don't have to panic about making sure that each minute figure is perfect. The IRS isn't going to hunt you down and send you to jail over a simple mistake - even they understand that we're all human. If you've lost some information that's necessary to your tax return, do your best to fill it out using reasonable estimates. Don't let perfectionism get in the way of filing.

Mistake 3: Going it alone
We aren't all tax experts, and that becomes particularly clear when you start filling out the labyrinthine forms. And if you've had any major (or even minor) changes to your life this year, the whole process can get even more confusing. Getting help from a tax professional is much more affordable than you might imagine, and can pay off in a lot of ways, not least of which could be a lower overall tax bill.

Mistake 4: Not reviewing your work
You had to do it for your homework, but you should be doing it for your taxes, too. Going back to your taxes with fresh eyes can help you catch mistakes or areas that were simply missed. Check the details. Are your Social Security numbers right? Were any credits or deductions missed?

Mistake 5: Being afraid to ask questions
The old axiom "there are no dumb questions" applies to your taxes. If you're not an expert, there will almost certainly be something that you don't understand or find confusing. Luckily, there are plenty of resources out there that can answer your questions. You can go directly to the IRS website or the IRS help line, but if you still need more assistance, ask your question at Equifax's blog or check with a tax professional.

Mistake 6: Not being careful with direct deposit
The advent of direct deposit has been a benefit to those waiting for their tax refunds, but you have to do the footwork for the IRS. They can only deposit the funds into the account you tell them to use, so make sure that the information you provide is correct. If there's a mistake and your money is deposited into the wrong account, it's a nightmare, at best, to get it back. At worst, you might not get it back at all.

Preparing taxes might never be your favorite activity, but it doesn't need to be a painful experience. Get the help you need, be cautious and don't let the stress get to you - tax season will be done before you know it. Have you made these six tax mistakes? How to avoid them this year
Category: Business